Skip to main content
. 2020 Apr 24;5(5):943–953. doi: 10.1093/jalm/jfaa038

Fig. 1.

Fig. 1

Development and characterization of hepcidin C-ELISA. (A) Dose response curve starting at 400 ng/mL with serial dilutions. Structurally similar peptides were compared to assess selectivity. Hepcidin-10 to -25 is an N-terminally truncated hepcidin peptide. (B) Comparison of monoclonal hepcidin C-ELISA (n = 292) with a previously described polyclonal C-ELISA (1).